Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,447 stories, page 150 of 608

Advanced search

🌍Aug 29Industryeledon.comTier 1 · Company source

Rethinking rejection in kidney transplant

Eledon PharmaceuticalsOriginal source

🇺🇸Aug 29Researchnews.nm.orgTier 2 · Direct publisher

Northwestern Medicine Marianjoy Rehabilitation Hospital Helps Patients with Multiple Sclerosis Stay Active Through Cooling Vest Program

Northwestern MedicineOriginal source

🇺🇰Aug 29Regulatorygov.ukTier 1 · Regulatory source

Terminally Ill Adults (End of Life) Bill 2026

Information relating to the Terminally Ill Adults (End of Life) Bill, which was introduced to the Ho...

UK Department of Health and Social CareOriginal source

🇺🇰Aug 29Regulatorygov.ukTier 1 · Regulatory source

Terminally Ill Adults (End of Life) Bill 2026: ECHR memorandum

Memorandum on the European Convention on Human Rights (ECHR) relating to the Terminally Ill Adults (...

UK Department of Health and Social CareOriginal source

🇺🇰Aug 29Regulatorygov.ukTier 1 · Regulatory source

Terminally Ill Adults (End of Life) Bill 2026: equality impact assessment

The equality impact assessment considers the impacts of the Terminally Ill Adults (End of Life) Bill...

UK Department of Health and Social CareOriginal source

🇺🇰Aug 29Regulatorygov.ukTier 1 · Regulatory source

Terminally Ill Adults (End of Life) Bill 2026: impact assessment

The impact assessment considers the potential impacts of the Terminally Ill Adults (End of Life) Bil...

UK Department of Health and Social CareOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Cipla Pune Unit Loses Drug Sale Licences: What Triggered FDA Action?

outlookbusiness.comOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

TipRanksOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Fenwick partners see biotech IPO demand building

AxiosOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Bengaluru’s ‘Peptide Party’ cancelled after Karnataka Food Safety and Drug Administration seeks...

Moneycontrol.comOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe-Led Maharashtra FDA Cancels Cipla Unit's Drug Licence Over Reactin Plus Irregularities

MenafnOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Best Biotech Stocks To Research - August 28th

MarketBeatOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Here’s why Maharashtra FDA cancelled drug sale licence of Cipla’s Pune unit

The StatesmanOriginal source

🌍Aug 29discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Cancels Cipla Facility Drug Licences Over Reactin Plus Irregularities

English Bombay SamacharOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Biotech companies bring on new HR talent in August

HR DiveOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Moderna and Merck’s positive preliminary cancer vaccine results could signal a ‘new era’ of cancer treatment, expert says

Healthcare BrewOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe-led Maharashtra FDA cancels Cipla unit's drug licence over Reactin Plus irregularities

LivemintOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals?

Currently.comOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals?

The Globe and MailOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Cipla Pune unit’s drug sale licence over violations

Zee NewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Show Me The Money: CADL Delivers 190%+ Gain In Less Than Six Months As BLA Filing Nears

RTTNewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Bank of America sees major upside in this biotech stock

thestreet.comOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Cytokinetics Shares Drop 5% Even as Company Delivers First Positive Phase 3 Results in Non-Obstructive HCM

TechStock²Original source

🌍Aug 28Regulatorywho.intTier 1 · Regulatory source

Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo

WHO Disease Outbreak NewsOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs

STATOriginal source

🇺🇸Aug 28Industryinvestor.lilly.comTier 1 · Company source

La FDA aprueba Mounjaro (tirzepatida) de Lilly para reducir el riesgo cardiovascular en adultos con diabetes tipo 2

Eli Lilly NewsOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

This week in charts: Biotech’s rebound is undeniable

BioPharma DiveOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

FDA cancels Cipla pharma’s CFA drug sale licence in Pune

The Indian ExpressOriginal source

🇺🇸Aug 28CROwcgclinical.comTier 2 · Direct publisher

FDA’s Updated IND Safety Reporting Guidance: What Changed, What Didn’t, and What to Do Now

WCG (IRB)Original source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

India News | Maharashtra FDA Cancels Licence of Prominent Pharma Company in Pune

LatestLYOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Cancer drug trial shows no sign of tumors—here's what happens next

NewsweekOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Pune pharma firm’s drug sale licences

The News MillOriginal source

🇪🇸Aug 28Researchcrg.euTier 2 · Direct publisher

Self-blinking ‘fairy lights’ allow DNA to be imaged at double helix width resolution

CRG Barcelona GenomicsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels licence of prominent pharma company in Pune

ANI NewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Annex 1 turns three: spotlight on sterile manufacturing

The Pharma LetterOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Cancels Cipla Pune Unit’s Drug Licence Over Reactin Plus Lapses

Republic WorldOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Weekly Buzz: GILD, ROIV Win FDA Nod; BHVN, LLY Strike Deal; SYRE Misses Monotherapy Goal

RTTNewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Has Ultragenyx Pharmaceutical (RARE) Fallen Far Enough After Gene Therapy Approval?

simplywall.stOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Cipla unit's drug licences in Pune over Reactin Plus recall, storage lapses

India TV NewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Miami Biotech Collective Rings the Nasdaq Stock Market Opening Bell

NasdaqOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Clinical trial tests new way to treat common inherited heart disease

OHSU NewsOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Cancels Drug Sale Licences Of Cipla Pharma & Life Sciences’ Pune C&F Unit Over Reactin Plus

Free Press JournalOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

FDA cancels Cipla Pune unit's licence over Reactin Plus violations; firm contests

India TodayOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Viking Therapeutics Stock (VKTX) Opinions on Phase 3 Obesity Drug Data Timing

Quiver QuantitativeOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Cipla Pharma’s Pune drug licences, seizes ₹11.19 lakh stock

CNBC TV18Original source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA cancels Cipla Pharma’s Pune unit drug sale licence

CNBC TV18Original source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

FDA cancels drug sale licences of Cipla Pharma & Life Sciences's Pune Carry and Forwarding unit

DailyhuntOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violation

The Economic TimesOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

STATOriginal source

🇪🇺Aug 28Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Standardized patient‑friendly computational language mapping to guide epilepsy surgery

CORDISOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

FDA cancels drug sale licences of Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit

The HinduOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Misbranding, storage lapses: FDA cancels Cipla Pune unit’s drug licence over Reactin Plus violations

The Times of IndiaOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Trump's pick for FDA faces scrutiny after cyclospora outbreak

BBCOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Biotech firms point to sustainability benefits of NGTs

FruitnetOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

New Haven biotech BioXcel files for bankruptcy, agrees to potential $145M sale

Hartford Business JournalOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio

Fierce BiotechOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

LIVE: Miami Biotech Collective Rings the Opening Bell

NasdaqOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

mRNA Cancer Vaccine Met Endpoints in Adjuvant Melanoma

Oncology Nursing NewsOriginal source

🌍Aug 28discoverynews.google.comTier 2 · Trade media

Fierce Pharma Asia—Roche’s $2.5B obesity deal; Akeso CEO’s defense; Lawmaker’s reflection on China

Fierce PharmaOriginal source

🌍Aug 28discoverynews.google.comTier 3 · Aggregated media

Symbiosis Pharmaceutical Services appoints Jay Chima as VP - business development in response to growing demand for biologics

Pharmabiz.comOriginal source